Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic Therapy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Luo, Zhenyu ^a   Zheng, Mingbin ^a,b   Zhao, Pengfei ^a   Chen, Ze ^a   Siu, Fungming ^c   Gong, Ping ^a   Gao, Guanhui ^a   Sheng, Zonghai ^a   Zheng, Cuifang ^a   Ma, Yifan ^a   Cai, Lintao ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETIC MATERIAL; HEMOGLOBIN; INDOCYANINE GREEN; NANOPARTICLE; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; FEMALE; HUMAN; MCF-7 CELL LINE; METABOLISM; MOUSE; PHOTOCHEMOTHERAPY; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE; TUMOR HYPOXIA;

ANIMALS; BIOMIMETIC MATERIALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HEMOGLOBINS; HUMANS; INDOCYANINE GREEN; MCF-7 CELLS; MICE; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; TISSUE DISTRIBUTION; TUMOR HYPOXIA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84962548308     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23393     Document Type: Article

References (35)

1. Dolmans, D. E., Fukumura, D., Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380-387 (2003).
2. Voon, S. H. et al. In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy. Small 10, 4993-5013 (2014).
3. Zheng, M. et al. Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano 7, 2056-2067 (2013).
4. Zhao, P. et al. Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles. Biomaterials 35, 6037-6046 (2014).
5. Dvorak, H. F., Weaver, V. M., Tlsty, T. D., Bergers, G. Tumor microenvironment and progression. J. Surg. Oncol. 103, 468-474 (2011).
6. Brown, J. M., Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4, 437-447 (2004).
7. Kirtane, A. R., Kalscheuer, S. M., Panyam, J. Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities. Adv. Drug Deliv. Rev. 65, 1731-1747 (2013).
8. Chen, H., Tian, J., He, W., Guo, Z. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells. J. Am. Chem. Soc. 137, 1539-1547 (2015).
9. Usacheva, M., Swaminathan, S. K., Kirtane, A. R., Panyam, J. Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles. Mol. Pharm. 11, 3186-3195 (2014).
10. Fleming, I. N. et al. Imaging tumour hypoxia with positron emission tomography. Br. J. Cancer 112, 238-250 (2015).
11. Li, T., Jing, X., Huang, Y. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells. Macromol. Biosci. 11, 865-875 (2011).
12. Gould, S. A. et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J. Am. Coll. Surg. 195, 445-452 (2002).
13. Chang, T. M. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond. Artif. Cells. Blood Substit. Immobil. Biotechnol. 40, 197-199 (2012).
14. Shorr, R., Viau, A., Abuchowski, A. Phase 1B safety evaluation of PEG hemoglobin as an adjuvant to radiation therapy in human cancer patients. Artif. Cells Blood Substit. Immobil. Biotechnol. 24, 407 (1996).
15. Yu, B., Chang, T. M. S. In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanoma. Melanoma Res. 14, 197-202 (2004).
16. Su, X. et al. Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the Vc, NAC, TEMPO and their reductant system. Artif. Cells Nanomed. Biotechnol. 42, 222-228 (2014).
17. Bonaventura, C. et al. Molecular controls of the oxygenation and redox reactions of hemoglobin. Antioxid. Redox Signal. 18, 2298-2313 (2013).
18. Buehler, P. W., Alayash, A. I. Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion 44, 1516-1530 (2004).
19. Vandegriff, K. D. et al. Impact of acellular hemoglobin-based oxygen carriers on brain apoptosis in rats. Transfusion 54, 2045-2054 (2014).
20. Yoneya, S. et al. Binding properties of indocyanine green in human blood. Invest. Ophthalmol. Vis. Sci. 39, 1286-1290 (1998).
21. Mordon, S., Devoisselle, J. M., Soulie-Begu, S., Desmettre, T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc. Res. 55, 146-152 (1998).
22. Ojugo, A. S. et al. Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous 19F and 31P probes. NMR Biomed. 12, 495-504 (1999).
23. Wang, Y., Lin, A., Loake, G., Chu, C. H2O2-induced leaf cell death and the crosstalk of reactive nitric/oxygen species. J. Integr. Plant Biol. 55, 202-208 (2013).
24. Dysart, J. S., Patterson, M. S. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 50, 2597-2616 (2005).
25. Kowalczyk, A., Puchala, M., Wesolowska, K., Serafin, E. Inactivation of alcohol dehydrogenase (ADH) by ferryl derivatives of human hemoglobin. Biochim. Biophys. Acta 1774, 86-92 (2007).
26. Lu, N. et al. Tyrosine can protect against oxidative stress through ferryl hemoglobin reduction. Toxicol. In Vitro 28, 847-855 (2014).
27. Peng, C. et al. Multimodal image-guided photothermal therapy mediated by 188Re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano 5, 5594-5607 (2011).
28. Kim, T. I., Jeong, K. H., Shin, M. K. Verrucous epidermal nevus (VEN) successfully treated with indocyanine green (ICG) photodynamic therapy (PDT). JAAD Case Reports 1, 312-314 (2015).
29. Meister, J. et al. Indocyanine green (ICG) as a new adjuvant for the antimicrobial photo-dynamic therapy (aPDT) in dentistry. Proc. SPIE 8929, 89290T (2014).
30. Raemdonck, K., Braeckmans, K., Demeester, J., De Smedt, S. C. Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery. Chem. Soc. Rev. 43, 444-472 (2014).
31. Nakao, A. et al. A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer. Cancer Gene Ther. 18, 167-175 (2011).
32. Duan, L. et al. Highly loaded hemoglobin spheres as promising artificial oxygen carriers. ACS Nano 6, 6897-6904 (2012).
33. Abagyan, R., Totrov, M., Kuznetsov, D. ICM-a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15, 488-506 (1994).
34. Xiong, Y. et al. Hemoglobin-based oxygen carrier microparticles: synthesis, properties, and in vitro and in vivo investigations. Biomacromolecules 13, 3292-3300 (2012).
35. Abraham, B. et al. Isolated Hb providence ? 82Asn and ? 82Asp fractions are more stable than native HbA0 under oxidative stress conditions. Biochemistry 50, 9752-9766 (2011).